What is Inhibrx Biosciences, Inc.'s shares (diluted)?

Inhibrx Biosciences, Inc. (INBX) reported shares (diluted) of 15.6M in Q1 2026.

How has Inhibrx Biosciences, Inc.'s shares (diluted) changed year-over-year?

Inhibrx Biosciences, Inc.'s shares (diluted) increased by 0.8% year-over-year, from 15.5M to 15.6M.

What does shares (diluted) mean?

The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Inhibrx Biosciences, Inc. INBX Shares (Diluted)

Shares (Diluted) at other companies

PfizerPFE

5.7B+0.4%

Rogers CorporationROG

17.9M-3.2%

Gilead SciencesGILD

1.3B-0.4%

Nuvation BioNUVB

377.5M+11.5%

ArriVent BioPharma, Inc.AVBP

45.1M+32.9%

ImmunomeIMNM

113.1M+42.5%

Other financials

Income statement

See full

Revenue--100%

Operating income-$30.9M+27.9%

Net income-$33.4M+22.8%

EPS (diluted)-$2.15+23.2%

Balance sheet

See full

Cash & equivalents$161.7M-25.3%

Total debt$180.9M+69.8%

Total equity-$21.0M-122%

Total assets$184.0M-24.2%

Cash flow

See full

Operating cash flow-$38.0M-5.9%

CapEx--100%

Free cash flow-$38.0M-5.9%

Valuation

See full

Market cap$1.4B+546%

Enterprise value$1.42B+1,233%

P/S1,073.7×-280×

Profitability

See full

Operating margin-10,386.5%-5,025pp

Net margin-10,773.5%-878,492pp

FCF margin-9,986.5%-4,727pp

Returns & leverage

See full

Return on equity-197.8%-2,158pp

Debt / equity13.4×+13.3×

Current ratio6.5×+1.3×

Where this comes from

Reported directly by Inhibrx Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inhibrx Biosciences, Inc.'s shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Inhibrx Biosciences, Inc.'s shares (diluted)?: Inhibrx Biosciences, Inc. (INBX) reported shares (diluted) of 15.6M in Q1 2026.
How has Inhibrx Biosciences, Inc.'s shares (diluted) changed year-over-year?: Inhibrx Biosciences, Inc.'s shares (diluted) increased by 0.8% year-over-year, from 15.5M to 15.6M.
What does shares (diluted) mean?: The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.